Novavax, Inc. (NVAX)

9.575 -0.42 (-4.15%) USD  |  NASDAQ  |  Mar 06, 12:39
More

Novavax Commercial Paper Liability (Annual Per Share)

Commercial Paper Liability (Annual Per Share) Chart

View Commercial Paper Liability (Annual Per Share) for NVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Commercial Paper Liability (Annual Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Commercial Paper Liability (Annual Per Share) Range, Past 5 Years

View Commercial Paper Liability (Annual Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Commercial Paper Liability (Annual Per Share) Benchmarks

View Commercial Paper Liability (Annual Per Share) Benchmarks
Start Trial
Merck & Co., Inc. --
Pfizer Inc. Upgrade
Moderna, Inc. --
Intellia Therapeutics, Inc. --
Recursion Pharmaceuticals, Inc. --